UBS Group’s Globavend GVH Stock Holding History

UBS Group’s Portfolio GVH Stock Details GVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.48K	Buy	3,801 +2,876	+311%	+$3.45K	﹤0.01%	8505
2025 Q4	$1.33K	Sell	925 -34	-4%	-$146	﹤0.01%	9623
2025 Q3	$4.4K	Buy	+959	New	+$6.81K	﹤0.01%	8953
2025 Q2	–	Sell	-153	Closed	-$17.2K	–	10490
2025 Q1	$17.2K	Buy	153 +37	+32%	+$5.18K	﹤0.01%	8329
2024 Q4	$15.6K	Buy	116 +30	+35%	+$4.4K	﹤0.01%	8039
2024 Q3	$14.2K	Sell	86 -1,107	-93%	-$154K	﹤0.01%	7552
2024 Q2	$210K	Buy	1,193 +1,192	+119,200%	+$296K	﹤0.01%	5626
2024 Q1	$278	Buy	+1	New	+$221	﹤0.01%	8660

Other funds holding GVH

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

UBS Group's GVH Position: Q1 2026 in Review

UBS Group increased its Globavend (GVH) stake by 311% in Q1 2026, buying an estimated $3.45K and bringing the position to 3,801 shares worth $8.48K. The position accounts for ﹤0.01% of the portfolio, ranked #8505.

UBS Group first reported a position in GVH in Q1 2024 and has held it in 8 quarters since. The position peaked at $210K in Q2 2024. 5 funds tracked by Wall St. Rank hold GVH as of Q1 2026.

UBS Group held 3,801 shares of Globavend worth $8.48K as of Q1 2026.
UBS Group bought 2,876 Globavend shares in Q1 2026, an estimated $3.45K.
Globavend made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8505 holding.
UBS Group first reported a position in Globavend in Q1 2024 and has held it in 8 quarters since.
UBS Group's Globavend position peaked at $210K in Q2 2024.
5 funds tracked by Wall St. Rank held Globavend as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.